AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSF2 | Acyl-CoA synthetase family member 2 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ARSD | Arylsulfatase D | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BCAM | Basal cell adhesion molecule (Lutheran blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BOC | BOC cell adhesion associated, oncogene regulated | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf85 | Chromosome 1 open reading frame 85 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA2D1 | Calcium channel, voltage-dependent, alpha 2/delta subunit 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD164 | CD164 molecule, sialomucin | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD164L2 | CD164 sialomucin-like 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD276 | CD276 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD300A | CD300a molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD300LF | CD300 molecule-like family member f | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |